<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open Diabetes Res Care</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open Diabetes Res Care</journal-id><journal-id journal-id-type="hwp">bmjdrc</journal-id><journal-id journal-id-type="publisher-id">bmjdrc</journal-id><journal-title-group><journal-title>BMJ Open Diabetes Research &#x00026; Care</journal-title></journal-title-group><issn pub-type="epub">2052-4897</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31958293</article-id><article-id pub-id-type="pmc">6954743</article-id><article-id pub-id-type="publisher-id">bmjdrc-2019-000665</article-id><article-id pub-id-type="doi">10.1136/bmjdrc-2019-000665</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Care/Education/Nutrition</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>1866</subject></subj-group></article-categories><title-group><article-title>Efficacy of clindamycin compared with amoxicillin-metronidazole after a 7-day regimen in the treatment of periodontitis in patients with diabetes: a randomized clinical trial</article-title></title-group><contrib-group><contrib id="author-68188832" contrib-type="author"><name><surname>G&#x000f3;mez-Sandoval</surname><given-names>Juan Ram&#x000f3;n</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="author-68188877" contrib-type="author"><name><surname>Robles-Cervantes</surname><given-names>Jos&#x000e9; Antonio</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib id="author-68188938" contrib-type="author"><name><surname>Hern&#x000e1;ndez-Gonz&#x000e1;lez</surname><given-names>Sandra Ofelia</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib id="author-68188966" contrib-type="author"><name><surname>Espinel-Bermudez</surname><given-names>Mar&#x000ed;a Claudia</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib id="author-68188989" contrib-type="author"><name><surname>Mariaud-Schmidt</surname><given-names>Roc&#x000ed;o</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="author-68189018" contrib-type="author"><name><surname>Mart&#x000ed;nez-Rodr&#x000ed;guez</surname><given-names>Vianeth</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib id="author-68189039" contrib-type="author"><name><surname>Morgado-Castillo</surname><given-names>Karina Celia</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib id="author-68062551" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9025-9328</contrib-id><name><surname>Mercado-Sesma</surname><given-names>Arieh Rold&#x000e1;n</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution content-type="department">Departamento de Cl&#x000ed;nicas Odontol&#x000f3;gicas Integrales</institution>, <institution>Instituto de Invesigaci&#x000f3;n en Odontolog&#x000ed;a, Especialidad en Periodoncia, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud</institution>, <addr-line content-type="city">Guadalajara</addr-line>, <addr-line content-type="state">Jalisco</addr-line>, <country>Mexico</country></aff><aff id="aff2"><label>2</label><institution content-type="department">Servicio de Medicina Interna</institution>, <institution>Instituto Jalisciense de Cirug&#x000ed;a Reconstructiva, Secretar&#x000ed;a de Salud Jalisco</institution>, <addr-line content-type="city">Guadalajara</addr-line>, <addr-line content-type="state">Jalisco</addr-line>, <country>Mexico</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Unidad de Investigaci&#x000f3;n Biom&#x000e9;dica 02 y Divisi&#x000f3;n de Investigaci&#x000f3;n en Salud</institution>, <institution>Unidad M&#x000e9;dica de Alta Especialidad Hospital de Especialidades, Centro M&#x000e9;dico Nacional de Occidente, Instituto Mexicano del Seguro Social</institution>, <addr-line content-type="city">Guadalajara</addr-line>, <addr-line content-type="state">Jalisco</addr-line>, <country>Mexico</country></aff><aff id="aff4"><label>4</label><institution>Diabetes sin Complicaciones S.A de C.V</institution>, <addr-line content-type="city">Zapopan</addr-line>, <addr-line content-type="state">Jalisco</addr-line>, <country>M&#x000e9;xico</country></aff><aff id="aff5"><label>5</label><institution content-type="department">Departamento de Salud enfermedad como proceso individual and Centro de Investigaci&#x000f3;n Multidisciplinaria en Salud</institution>, <institution>Universidad de Guadalajara, Centro Universitario de Tonal&#x000e1;</institution>, <addr-line content-type="city">Tonal&#x000e1;</addr-line>, <addr-line content-type="state">Jalisco</addr-line>, <country>Mexico</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Arieh Rold&#x000e1;n Mercado-Sesma; <email>arieh.mercado@academicos.udg.mx</email></corresp></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>6</day><month>1</month><year>2020</year></pub-date><volume>8</volume><issue>1</issue><elocation-id>e000665</elocation-id><history><date date-type="received"><day>14</day><month>2</month><year>2019</year></date><date date-type="rev-recd"><day>11</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>26</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2020-06-01">http://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjdrc-2019-000665.pdf"/><abstract><sec><title>Objective</title><p>To determine the efficacy of clindamycin compared with amoxicillin-metronidazole after a 7-day regimen during nonsurgical treatment of periodontitis in patients with type 2 diabetes mellitus.</p></sec><sec><title>Research design and methods</title><p>In this double-blind, randomized clinical trial, a total of 42 patients with chronic periodontitis and type 2 diabetes were included. Patients were randomly assigned to treatment with either clindamycin or amoxicillin-metronidazole three times a day during 7&#x02009;days. Clinical determinations (probing depth, bleeding on probe, and plaque index) were performed to determine the extent and severity of periodontitis before and after the pharmacological treatment.</p></sec><sec><title>Results</title><p>After 7&#x02009;days of administration of clindamycin or amoxicillin-metronidazole, no differences were observed between the clinical determinations, probing depth (0.44 vs 0.50&#x02009;mm, p=0.624), plaque index (17.62 vs 15.88%, p=0.910), and bleeding on probing (16.12 vs 22.17%, p=0.163), respectively. There were no adverse events in either group.</p></sec><sec><title>Conclusion</title><p>The administration during 7&#x02009;days of clindamycin or amoxicillin/metronidazole showed the same efficacy for the reduction of probing depth, plaque index, and bleeding on probing in patients with periodontitis and type 2 diabetes.</p></sec></abstract><kwd-group><kwd>periodontal disease</kwd><kwd>type 2 diabetes</kwd><kwd>antibiotics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>special-feature</meta-name><meta-value>unlocked</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Significance of this study</title></caption><sec><title>What is already known about this subject?</title><list list-type="bullet"><list-item><p>Diabetes mellitus is a risk factor for periodontitis. The complications of chronic periodontitis are the progressive destruction of the periodontal ligament and alveolar bone. The use of mechanical debridement is the standard therapy. Because this procedure has some limitations the use of antibiotics is an option. However, some antibiotics show more efficacy.</p></list-item></list></sec><sec><title>What are the new findings?</title><list list-type="bullet"><list-item><p>Clindamycin during 7&#x02009;days has the same efficacy as amoxicillin/metronidazole. Clindamycin is a good option in periodontal therapy.</p></list-item><list-item><p>Short courses of antibiotic therapy reduce adverse events.</p></list-item></list></sec><sec><title>How might these results change the focus of research or clinical practice?</title><list list-type="bullet"><list-item><p>The use of short courses of antibiotic therapy is a good option which improves adherence, is less expensive, and has fewer adverse events.</p></list-item></list></sec></boxed-text><sec sec-type="intro" id="s1"><title>Introduction</title><p>Diabetes mellitus is a risk factor for gingivitis and periodontitis. Diabetic adults with poorly controlled glycemia had a 2.9-fold increased risk of having periodontitis compared with nondiabetic adult subjects.<xref rid="R1" ref-type="bibr">1 2</xref> It is estimated that periodontitis affects 740&#x02009;million people worldwide.<xref rid="R2" ref-type="bibr">2</xref><xref rid="R3" ref-type="bibr">3</xref> The link between both pathologies is an altered immunoinflammatory response and changes in gingival microflora as a consequence of chronic hyperglycemia. This pathogenic flora has a relationship with worsened periodontitis. The complications of chronic periodontitis are the progressive destruction of the periodontal ligament and alveolar bone.<xref rid="R4" ref-type="bibr">4&#x02013;7</xref> Standard periodontal treatment includes mechanical debridement to remove biofilm and calculus from the affected root surfaces.<xref rid="R8" ref-type="bibr">8 9</xref> Because this procedure has some limitations, the use of antimicrobial agents is an option to eradicate pathogenic bacteria in deep pockets, root furcations, and concavities. In this sense, the objective of periodontal antibiotic therapy is to reduce the number of periodontal pathogens and produce a healthy periodontium in a short time.<xref rid="R10" ref-type="bibr">10 11</xref> The most used treatment is the combination of amoxicillin with metronidazole (AMX-MET) due their synergistic effect and their wide spectrum of activity.<xref rid="R12" ref-type="bibr">12</xref> However, there are reports of higher resistance in some pathogens compared with other antibiotics. Rams <italic>et al</italic>, mentioned a resistance of 55% vs 30.3% with the use of AMX-MET compared with clindamycin, respectively.<xref rid="R13" ref-type="bibr">13</xref> Clindamycin is a semisynthetic derivative of lincomycin, used in the treatment of dental, bone or joint infections. Moreover, it has been used in the treatment of foot infections in patients with diabetes and in the prevention of endocarditis.<xref rid="R14" ref-type="bibr">14&#x02013;16</xref></p><p>In spite of both antibiotic regimens being effective against anaerobic microorganisms, there are no studies that compare both therapies in the treatment of periodontitis in patients with diabetes.</p><p>The purpose of the present study was to determine the efficacy of systemic clindamycin compared with amoxicillin/metronidazole in the treatment of periodontitis during nonsurgical periodontal treatment in patients with type 2 diabetes.</p></sec><sec id="s2"><title>Research design and methods</title><sec id="s2-1"><title>Study design</title><p>A parallel, randomized, double-blind, single-center clinical trial was designed to compare the efficacy of two antibiotic therapies. The study was carried out on patients at the Integral Dentistry Clinics of the University Center of Health Sciences of the University of Guadalajara in Jalisco, Mexico. The participants attended for dental care from August 2015 to December 2016. The study protocol was approved by the ethical committee of the Universitary Center of Health Sciences of University of Guadalajara and conducted according to Good Clinical Practice and the principles of the Declaration of Helsinki. All patients provided written informed consent before the initiation of study procedures. The protocol was registered in Clinicaltrials.gov NCT 03374176.</p><p>The sample size was calculated with a 95% confidence level and statistical power of 80%. A SD of 1.0&#x02009;mm with an expected difference of 1.0&#x02009;mm probing depth reduction between treatments. This resulted in a total of 14 patients per arm; however, considering an attrition of about 20%, it was established that least 21 subjects should be included in each treatment group.</p></sec><sec id="s2-2"><title>Patient population</title><sec id="s2-2-1"><title>Criteria for selection</title><p>Patients of both sexes (aged &#x0003e;18&#x02013;70 years) with a diagnosis of chronic periodontitis moderately localized according to the 1999 International World Workshop for a Classification of Periodontal Diseases and Conditions and a history of type 2 diabetes with a Hb<sub>A1C</sub>&#x0003c;8% and a fasting plasma glucose (FPG) &#x0003c;180&#x02009;mg/dL, were chosen. Diabetes should not have been diagnosed more than 10 years previously. Patients with aggressive periodontitis, pregnant or lactating females, persons who required antibiotic premedication for the performance of periodontal examination and treatment or who had received antibiotic treatment in the previous 3&#x02009;months were excluded. A history of anti-in&#x0fb02;ammatory therapy during the preceding 6&#x02009;months or who had received a course of periodontal treatment within the previous 6&#x02009;months, who were allergic to penicillin, metronidazole or clindamycin, who smoked or were not able to provide consent to participate in the study were also excluded. All the included participants received the appropriate treatment for glucose control as determined by their specialist doctor.</p></sec><sec id="s2-2-2"><title>Intervention</title><p>Participants were randomly allocated 1:1 to receive 300&#x02009;mg clindamycin plus placebo or 500&#x02009;mg amoxicillin plus 250&#x02009;mg metronidazole and allocated using a random numbers generator. AMX and MET are distinctive pills, so we decided to use placebo pills plus clindamycin with the objective of eliminating possible bias. These drugs were blinded in bottles with the same characteristics and neither the patient nor the researcher knew what treatment was being applied. Subjects in both groups were instructed to take the treatment three times a day for 7&#x02009;days. The procedure was explained and managed by a previously trained nurse.</p></sec><sec id="s2-2-3"><title>Assessments</title><p>Participants were evaluated twice. A complete periodontal examination was conducted, including a full medical and dental history, an intraoral examination and full-mouth periodontal probing. A radiographic examination was undertaken using either periapical films or a pantomogram. Periodontal therapy was initiated within 1&#x02009;month of the baseline screening examination. A standard cycle of periodontal therapy consisting of oral hygiene instruction, supragingival and subgingival mechanical instrumentation scaling and root planing (SRP) was performed by two experienced therapists.</p></sec><sec id="s2-2-4"><title>Clinical parameters</title><p>Clinical parameters were assessed using a North Caroline Periodontal Probe by the calibrated examiner at six sites. Full-mouth plaque scores were recorded by assigning a binary score to each surface (1 for plaque present, 0 for absent) and by calculating the proportion of all tooth surfaces on which plaque was detected using a disclosing tablet. Similarly, a full-mouth proportion of bleeding sites was calculated after dichotomously assessing bleeding on probing from the bottom of the pocket with a manual probe with a force of 0.3&#x02009;N. Full-mouth probing pockets depth (PPD) and recession of the gingival margin were recorded at the same time with measurements rounded to the nearest millimeter.</p></sec><sec id="s2-2-5"><title>Statistical analysis</title><p>Age, FPG, Hb<sub>A1C</sub>, tooth, and sounding depth were presented as means and SD. The intragroup differences were calculated with Wilcoxon rank test. The intergroup differences were calculated with Mann-Whitney test. Sex, bacterial plaque, and bleeding to the sounding were summarized using proportions and analyzed with &#x003c7;&#x000b2;. In all analyses, a p&#x0003c;0.05 (two tailed) was considered statistically significant. All statistical analyses were conducted using SPSS software (IBM, Armonk, New York, USA) V.21.</p></sec></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>A total of 42 patients were enrolled in this study; <xref ref-type="fig" rid="F1">figure 1</xref> shows a flow diagram. The comparative analysis of the baseline measurements showed no differences between study groups (<xref rid="T1" ref-type="table">table 1</xref>). After antimicrobial therapy, no significant intragroup differences in probing depth, plaque index, and bleeding on probing were observed. There were no statistically significant differences between the groups when the clinical variables were evaluated (<xref ref-type="fig" rid="F2 F3">figures 2 and 3</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow chart of the study design</p></caption><graphic xlink:href="bmjdrc-2019-000665f01"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Comparison between groups in final sounding depth. Value in mean. P&#x02264;0.05. Mann-Whitney test. AMX, amoxicillin; MET, metronidazole.</p></caption><graphic xlink:href="bmjdrc-2019-000665f02"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Comparison between groups in final clinical assessments. Value in mean. P&#x02264;0.05. &#x003c7;<sup>2</sup>-test. AMX, amoxicillin; MET, metronidazole.</p></caption><graphic xlink:href="bmjdrc-2019-000665f03"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Basal demographics characteristics and clinical parameters of study groups</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1">AMX+MET</td><td align="left" valign="bottom" rowspan="1" colspan="1">Clindamycin</td><td align="left" valign="bottom" rowspan="1" colspan="1">P value</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex, F/M (%)*</td><td align="char" char="." rowspan="1" valign="top" colspan="1">10/11 (48/53)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">14/7 (67/33)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.212</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, years</td><td align="char" char="." rowspan="1" valign="top" colspan="1">52.5 (8.0)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">52.0 (10.6)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.950</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FPG, mg/dL</td><td align="char" char="." rowspan="1" valign="top" colspan="1">134.1 (23.3)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">136.3 (25.7)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.950</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1C, %</td><td align="char" char="." rowspan="1" valign="top" colspan="1">7.1 (0.4)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">7.3 (0.4)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.120</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tooth, n</td><td align="char" char="." rowspan="1" valign="top" colspan="1">25 (3)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">24 (5)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.650</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sites, n</td><td align="char" char="." rowspan="1" valign="top" colspan="1">147 (25)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">144 (29)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.705</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Probing depth, mm</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2.4 (0.6)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">2.6 (0.6)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.180</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Plaque index, (%)*</td><td align="char" char="." rowspan="1" valign="top" colspan="1">40.4 (22.9)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">40.7 (21.9)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.850</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Bleeding on probing (%)*</td><td align="char" char="." rowspan="1" valign="top" colspan="1">42.4 (24.2)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">55.6 (25.8)</td><td align="char" char="." rowspan="1" valign="top" colspan="1">0.070</td></tr></tbody></table><table-wrap-foot><fn id="T1_FN1"><p>P&#x02264;0.05.</p></fn><fn id="T1_FN2"><p>*Pearson &#x003c7;<sup>2</sup> test. U-Mann-Whitney test.</p></fn><fn id="T1_FN3"><p>&#x02020;Values in mean (SD).</p></fn><fn id="T1_FN4"><p>AMX+MET, amoxicillin with metronidazole; F, female; FPG, fasting plasma glucose; M, male.</p></fn></table-wrap-foot></table-wrap><p>No loss of teeth between groups compared with baseline was reported. No serious adverse events occurred during the study.</p></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Complications due to diabetes have negative effects on different aspects of patients&#x02019; health: economics, quality of life, and self-esteem. Periodontitis is a common complication in patients with diabetes, not frequently mentioned. Poor glycemic control associated with periodontitis can modify the connective tissues response and the progressive destruction of periodontal structures. Periodontal treatment may have a positive effect on hyperglycemia, independently of diabetic treatment.<xref rid="R17" ref-type="bibr">17&#x02013;19</xref></p><p>Recent evidence has shown that the use of adjunct systemic antibiotics with SRP in patients with diabetes is inconclusive.<xref rid="R10" ref-type="bibr">10&#x02013;12</xref> Santos <italic>et al</italic>, in a systematic review, evaluated the effect of different antibiotics on periodontal parameters in patients with diabetes. The results showed a positive significant effect with the use of SRP plus antibiotics, reducing the probing depth and bleeding in probing.<xref rid="R20" ref-type="bibr">20</xref> Our results showed a similar reduction in both parameters with the use of clindamycin or amoxicillin-metronidazole. In addition, these findings are in concordance to other randomized clinical trials that had used systemic antibiotics in similar populations.<xref rid="R21" ref-type="bibr">21&#x02013;25</xref></p><p>Several authors refer to SRP plus amoxicillin-metronidazole as the most effective therapy for periodontitis in patients with diabetes when compared with several antibiotics.<xref rid="R26" ref-type="bibr">26&#x02013;29</xref> However, no studies compare AMX-MET with clindamycin. Clindamycin is a broad-spectrum antibiotic, active against aerobic and anaerobic bacteria including coverage against beta-lactamase producing pathogens. It could be considered an option in the treatment of diabetic infections in different sites.<xref rid="R30" ref-type="bibr">30</xref></p><p>Unlike other studies, the present trial shows that clinical benefit can be achieved with 7&#x02009;days of antibiotic treatment vs the 14 days prescribed by other authors.<xref rid="R31" ref-type="bibr">31</xref> According to a rational use of antibiotics, the duration of treatment should be the shortest possible and most acute oral infections are resolved in less than 7 days.<xref rid="R32" ref-type="bibr">32</xref> Moreover, the use of short courses have some advantages: fewer adverse events, more adhesion, lower costs, and so on.<xref rid="R32" ref-type="bibr">32</xref> There is a tendency to use higher doses for a shorter time, but the evidence about this practice is not conclusive.<xref rid="R33" ref-type="bibr">33</xref> We consider a better option is to use standard doses for a shorter time as complement to periodontitis treatment.</p><p>The intragroup significant differences between baseline and the final visit were observed in both groups. The efficacy of amoxicillin and metronidazole in the treatment of periodontitis is established evidence. However, the use of clindamycin is a new option in oral infections.</p><p>In addition, in the present study, no teeth were reported to have been lost in either group. The principal limitation of the present study was the absence of a group with SRP plus placebo. This study design, using a placebo group, could help us to evaluate the efficacy of clindamycin versus SRP alone. However, this study shows that clindamycin is a new option similar to AMX-MET for periodontitis treatment in patients with diabetes.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>The administration during 7&#x02009;days of clindamycin or amoxicillin/metronidazole showed the same efficacy for reducing probing depth, plaque index, and bleeding on probing in patients with periodontitis and type 2 diabetes.</p></sec></body><back><ack><p>We appreciate the comments and correction style of Paul Riordan of Write 2 Publish. We also appreciate the comments and support of Ra&#x000fa;l Baptista Rosas and Luis Cortes of Research Department of CUTonal&#x000e1;.</p></ack><fn-group><fn fn-type="other"><p><bold>Contributors:</bold> JRGS, JARC, SOHG, MCEB, and ARMS participated in the design of the study. JRGS, JARC, SOHG, RMS, VMR, and KCMC participated in data interpretation. MCEB and ARMS performed the statistical analysis of the data. JRGS, RMS, and VMR participated in recruited and evaluation participants and data collection. All authors helped to draft the manuscript and read and approved the final manuscript.</p></fn><fn fn-type="other"><p><bold>Funding:</bold> The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.</p></fn><fn fn-type="COI-statement"><p><bold>Competing interests:</bold> None declared.</p></fn><fn fn-type="other"><p><bold>Patient consent for publication:</bold> Not required.</p></fn><fn fn-type="other"><p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p></fn><fn fn-type="other"><p><bold>Data availability statement:</bold> Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Preshaw</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Lalla</surname><given-names>E</given-names></name></person-group>
<article-title>A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes</article-title>. <source>J Clin Periodontol</source><year>2013</year>;<volume>40 Suppl 14</volume>:<fpage>S113</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.12059</pub-id><pub-id pub-id-type="pmid">23627323</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>GW</given-names></name></person-group>
<article-title>Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population</article-title>. <source>Community Dent Oral Epidemiol</source><year>2002</year>;<volume>30</volume>:<fpage>182</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-0528.2002.300304.x</pub-id><pub-id pub-id-type="pmid">12000341</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kassebaum</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Bernabe</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Dahiya</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression</article-title>. <source>J Dental Res</source><year>2014</year>;<volume>93</volume>:<fpage>1045</fpage>&#x02013;<lpage>53</lpage>.</mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchetti</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Monaco</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Procaccini</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Periodontal disease: the influence of metabolic syndrome</article-title>. <source>Nutr Metab</source><year>2012</year>;<volume>9</volume>
<pub-id pub-id-type="doi">10.1186/1743-7075-9-88</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lalla</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Papapanou</surname><given-names>PN</given-names></name></person-group>
<article-title>Diabetes mellitus and periodontitis: a tale of two common interrelated diseases</article-title>. <source>Nat Rev Endocrinol</source><year>2011</year>;<volume>7</volume>:<fpage>738</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2011.106</pub-id><pub-id pub-id-type="pmid">21709707</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Desta</surname><given-names>T</given-names></name>, <name name-style="western"><surname>He</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes alters the response to bacteria by enhancing fibroblast apoptosis</article-title>. <source>Endocrinology</source><year>2004</year>;<volume>145</volume>:<fpage>2997</fpage>&#x02013;<lpage>3003</lpage>. <pub-id pub-id-type="doi">10.1210/en.2003-1601</pub-id><pub-id pub-id-type="pmid">15033911</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bal</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Desta</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation</article-title>. <source>J Dent Res</source><year>2006</year>;<volume>85</volume>:<fpage>510</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1177/154405910608500606</pub-id><pub-id pub-id-type="pmid">16723646</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadkhoda</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Tari</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Owlia</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Comparison of 1-periodontal indices and cultural Porphyromonas gingivalis colony count in aggressive periodontitis patients treated by scaling and rootplanning with or without metronidazole gel</article-title>. <source>J Dent</source><year>2012</year>;<volume>9</volume>:<elocation-id>50</elocation-id>.</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greenstein</surname><given-names>G</given-names></name></person-group>
<article-title>Full-Mouth therapy versus individual quadrant root planing: a critical commentary</article-title>. <source>J Periodontol</source><year>2002</year>;<volume>73</volume>:<fpage>797</fpage>&#x02013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2002.73.7.797</pub-id><pub-id pub-id-type="pmid">12146540</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haffajee</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Socransky</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Gunsolley</surname><given-names>JC</given-names></name></person-group>
<article-title>Systemic anti-infective periodontal therapy. A systematic review</article-title>. <source>Ann Periodontol</source><year>2003</year>;<volume>8</volume>:<fpage>115</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1902/annals.2003.8.1.115</pub-id><pub-id pub-id-type="pmid">14971252</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herrera</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Sanz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jepsen</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients</article-title>. <source>J Clin Periodontol</source><year>2002</year>;<volume>29</volume>:<fpage>136</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-051X.29.s3.8.x</pub-id><pub-id pub-id-type="pmid">12787214</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soares</surname><given-names>GMS</given-names></name>, <name name-style="western"><surname>Mendes</surname><given-names>JAV</given-names></name>, <name name-style="western"><surname>Silva</surname><given-names>MP</given-names></name>, <etal>et al</etal></person-group>
<article-title>Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a secondary analysis of microbiological results from a randomized clinical trial</article-title>. <source>J Clin Periodontol</source><year>2014</year>;<volume>41</volume>:<fpage>366</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.12217</pub-id><pub-id pub-id-type="pmid">24834504</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rams</surname><given-names>TE</given-names></name>, <name name-style="western"><surname>Degener</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>van Winkelhoff</surname><given-names>AJ</given-names></name></person-group>
<article-title>Antibiotic resistance in human chronic periodontitis microbiota</article-title>. <source>J Periodontol</source><year>2014</year>;<volume>85</volume>:<fpage>160</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2013.130142</pub-id><pub-id pub-id-type="pmid">23688097</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brook</surname><given-names>I</given-names></name></person-group>
<article-title>Spectrum and treatment of anaerobic infections</article-title>. <source>J Infect Chemother</source><year>2016</year>;<volume>22</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.jiac.2015.10.010</pub-id><pub-id pub-id-type="pmid">26620376</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Segura-Egea</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Gould</surname><given-names>K</given-names></name>, <name name-style="western"><surname>&#x0015e;en</surname><given-names>BH</given-names></name>, <etal>et al</etal></person-group>
<article-title>Antibiotics in Endodontics: a review</article-title>. <source>Int Endod J</source><year>2017</year>;<volume>50</volume>:<fpage>1169</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1111/iej.12741</pub-id><pub-id pub-id-type="pmid">28005295</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brook</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>MAO</given-names></name>, <name name-style="western"><surname>S&#x000e1;ndor</surname><given-names>GKB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clindamycin in dentistry: more than just effective prophylaxis for endocarditis?</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2005</year>;<volume>100</volume>:<fpage>550</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tripleo.2005.02.086</pub-id><pub-id pub-id-type="pmid">16243239</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mealey</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Ocampo</surname><given-names>GL</given-names></name></person-group>
<article-title>Diabetes mellitus and periodontal disease</article-title>. <source>Periodontol 2000</source><year>2007</year>;<volume>44</volume>:<fpage>127</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0757.2006.00193.x</pub-id><pub-id pub-id-type="pmid">17474930</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lakschevitz</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Aboodi</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Tenenbaum</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes and periodontal diseases: interplay and links</article-title>. <source>Curr Diab Rev</source><year>2011</year>;<volume>7</volume>:<fpage>433</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.2174/157339911797579205</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Feres</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Retamal-Vald&#x000e9;s</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Influence of glycemic control on the levels of subgingival periodontal pathogens in patients with generalized chronic periodontitis and type 2 diabetes</article-title>. <source>J Appl Oral Sci</source><year>2017</year>;<volume>25</volume>:<fpage>82</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1590/1678-77572016-0302</pub-id><pub-id pub-id-type="pmid">28198980</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>CMML</given-names></name>, <name name-style="western"><surname>Lira-Junior</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>RG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Systemic antibiotics in periodontal treatment of diabetic patients: a systematic review</article-title>. <source>PLoS One</source><year>2015</year>;<volume>10</volume>:<elocation-id>e0145262</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0145262</pub-id><pub-id pub-id-type="pmid">26693909</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skurska</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dolinska</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Pietruska</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effect of nonsurgical periodontal treatment in conjunction with either systemic administration of amoxicillin and metronidazole or additional photodynamic therapy on the concentration of matrix metalloproteinases 8 and 9 in gingival crevicular fluid in patients with aggressive periodontitis</article-title>. <source>BMC Oral Health</source><year>2015</year>;<volume>15</volume>:<fpage>63</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1186/s12903-015-0048-0</pub-id><pub-id pub-id-type="pmid">26007680</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guzeldemir-Akcakanat</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gurgan</surname><given-names>CA</given-names></name></person-group>
<article-title>Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis</article-title>. <source>Med Oral</source><year>2015</year>;<volume>1</volume>:<fpage>e441</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4317/medoral.20552</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jepsen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Jepsen</surname><given-names>S</given-names></name></person-group>
<article-title>Antibiotics/antimicrobials: systematic and local administration in the therapy of mild to moderately advanced periodontitis</article-title>. <source>Periodontology</source><year>2016</year>;<volume>2000</volume>:<fpage>82</fpage>&#x02013;<lpage>112</lpage>.</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mombelli</surname><given-names>A</given-names></name></person-group>
<article-title>Antimicrobial profiles of periodontal pathogens and systemic antimicrobial therapy</article-title>. <source>J Clin Periodontol</source><year>2005</year>;<volume>32</volume>:<fpage>891</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2005.00807.x</pub-id><pub-id pub-id-type="pmid">15998274</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matarazzo</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Figueiredo</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Cruz</surname><given-names>SEB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study</article-title>. <source>J Clin Periodontol</source><year>2008</year>;<volume>35</volume>:<fpage>885</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2008.01304.x</pub-id><pub-id pub-id-type="pmid">18727657</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mestnik</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Feres</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Figueiredo</surname><given-names>LC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Short-Term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis</article-title>. <source>J Clin Periodontol</source><year>2010</year>;<volume>37</volume>:<fpage>353</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2010.01538.x</pub-id><pub-id pub-id-type="pmid">20447259</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silva</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Feres</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Oliveira Sirotto</surname><given-names>TA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial</article-title>. <source>J Clin Periodontol</source><year>2011</year>;<volume>38</volume>:<fpage>828</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2011.01763.x</pub-id><pub-id pub-id-type="pmid">21762197</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miranda</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Feres</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Perez-Chaparro</surname><given-names>PJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial</article-title>. <source>J Clin Periodontol</source><year>2014</year>;<volume>41</volume>:<fpage>890</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.12282</pub-id><pub-id pub-id-type="pmid">24930639</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamashiro</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Duarte</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Miranda</surname><given-names>TS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Amoxicillin plus metronidazole therapy for patients with periodontitis and type 2 diabetes: a 2-year randomized controlled trial</article-title>. <source>J Dent Res</source><year>2016</year>;<volume>95</volume>:<fpage>829</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1177/0022034516639274</pub-id><pub-id pub-id-type="pmid">27013640</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sp&#x000ed;&#x0017e;ek</surname><given-names>J</given-names></name>, <name name-style="western"><surname>&#x00158;ezanka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lincomycin</surname><given-names>RT</given-names></name></person-group>
<article-title>Lincomycin, clindamycin and their applications</article-title>. <source>Appl Microbiol Biotechnol</source><year>2004</year>;<volume>64</volume>:<fpage>455</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-003-1545-7</pub-id><pub-id pub-id-type="pmid">14762701</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flynn</surname><given-names>TR</given-names></name></person-group>
<article-title>What are the antibiotics of choice for odontogenic infections, and how long should the treatment course last?</article-title><source>Oral Maxillofac Surg Clin North Am</source><year>2011</year>;<volume>23</volume>:<fpage>519</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.coms.2011.07.005</pub-id><pub-id pub-id-type="pmid">21982604</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oberoi</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Dhingra</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Antibiotics in dental practice: how justified are we</article-title>. <source>Int Dent J</source><year>2015</year>;<volume>65</volume>:<fpage>4</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/idj.12146</pub-id><pub-id pub-id-type="pmid">25510967</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herrera</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Matesanz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bascones-Mart&#x000ed;nez</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Local and systemic antimicrobial therapy in periodontics</article-title>. <source>J Evid Based Dent Pract</source><year>2012</year>;<volume>12</volume>:<fpage>50</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S1532-3382(12)70013-1</pub-id></mixed-citation></ref></ref-list></back></article>